Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Retrospective Review of Cerebral Mycotic Aneurysms in 26 Patients: Focus on Treatment in Strongly Immunocompromised Patients with a Brief Literature Review
AJNR 34:823-827, Allen, L.M.,et al, 2013
Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features
AJNR 29:1036-1042, Bartynski,W.S., 2008
Reversible Posterior Leukoencephalopathy Syndrome
Intern Med J 35:83-90, Stott,V.L.,et al, 2005
The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000
Brain Infarction Following 5-Fluorouracil and Cisplatin Therapy
Neurol 52:899-901, Amrani,M.E.,et al, 1998
Neurologic Emergencies in Cancer Patients
Neurol Clin 16:1-37, Schiff,D.,et al, 1998
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Neurologic Complications of Systemic Cancer
In Neurologic Clinics 3:729-750, Patchell,R.A.&Posner,J.B., 1985
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022
Clinicopathologic Conference, Diffuse Large B-Cell Lymphoma
NEJM 386:977-986, Case 7-2022, 2022
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects
JENDSO 6:1-7, Hamidi, S.,et al, 2022
Atypical Posterior Reversible Encephalopathy Syndrome Associated with Lenvatinib Therapy in a Patient with Metastatic Thyroid-Cancer
Cancer Reports doi:10.1002/cnr2.1605, Abhishek, M.,et al, 2022
Imaging Findings in Children Presenting with CNS Nelarabine Toxicity
AJNR 43:1802-1809, Serrallach,B.L.,et al, 2022
A 59-Year-Old Woman Presenting with Diplopia, Dysarthria, Right-sided Weakness, and Encephalopathy
Neurol 97:e859-e864, Manzano, G.S.,et al, 2021
Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Delayed Complications of Cranial Irradiation
www.UptoDate.com, May, Dietrich, J.,et al, 2019
A 56-year-old woman with acute vertigo and diplopia
Neurol 90:748-752, Sharma, R.,et al, 2018
Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018
Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018
A Woman in her 40s with Headache and New-Onset Seizures
JAMA Neurol 74:476-480, Graham, M.S.,et al, 2017
A 47-year-old Woman with Left Shoulder Pain after a Fall
Neurol 83:e112-e116, Jerath, N.U.,et al, 2014
Characteristics of Intravascular Large B-Cell Lymphoma on Cerebral MR Imaging
AJNR 33:292-296, Yamamoto,A.,et al, 2012
Reversible Paraneoplastic Tonic Pupil
Neurol 78:1820-1822, Horta, E.,et al, 2012
Dropped Head Syndrome: Report of Three Cases During Treatment with a Mek Inhibitor
Neurol 79:1929-1932, Chen, X.,et al, 2012
Clinicopath Conf, Intravascular Large-B-Cell Lympoma
NEJM 362:1129-1138, Case 9-2010, 2010
CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009
Intracranial Hemorrhage in Patients Treated with Bevacizumab and Low-Molecular Weight Heparin
Clin Adv Hematol Oncol 5:375-379, Nguyen, T.D.,et al, 2007
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006
Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock
AJNR 27:2179-2190, Bartynski,W.S.,et al, 2006
Diffusion-Weighted Cranial MR Imaging Findings in a Patient with Hemophagocytic Syndrome
AJNR 27:1312-1314, Ozgen, B.,et al, 2006
NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005
Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping
Nueroradiology 46:978-983, Ahn, K.J.,et al, 2004
Paraneoplastic Chorea Associated with CRMP-5 Neuronal Antibody and Lung Carcinoma
Ann Neurol 51:625-630, Vernino,S.,et al, 2002
Severe Neurologic Complications After Hematopoietic Stem Cell Transplantation in Children
Neurol 59:1895-1904,E13, Farci,M.,et al, 2002
Reversible Posterior Leukoencephalopathy During the Treatment of Acute Lymphoblastic Leukemia
Neurol 56:388-391, Shin,R.K.,et al, 2001
Gemcitabine-Associated Posterior Reversible Encephalopathy Syndrome: MR Imaging and MR Spectroscopy Findings
Magnetic Resonance Imaging 19:129-132, Russell,M.T,et al, 2001
Guillain-Barre Syndrome in a Patient with Non-Hodgkins Lymphoma
Ann Oncol 11:217-220, Schwenk,D.Re.,et al, 2000
Neurologic Complications of Pediatric Lung Transplantation
Neurol 53:1542-1549, Wong,M.,et al, 1999
Dementia Following Treatment of Brain Tumors with Radiotherapy Administered Alone or in Combination with Nitrosourea-Based Chemotherapy: A Clinical and Pathological Study
J Neurooncol 41:137-149, Vigliani,M.C.,et al, 1999
Cisplatin Neurotoxicity Presenting as Reversible Posterior Leukoencephalopathy Syndrome
AJNR 19:415-417, 5911998., Ito,Y.,et al, 1998
Acute Leukoencephalopathies:Differential Diagnosis and Investigation
The Neurologist 4:148-166, Weinshenker,B.G.,et al, 1998
Second Malig in Young Children with Prim Brain Tumors Following Trtm with Prolonged Postop Chemo & Delay Irrad
Ann Neurol 44:313-316, 3001998., Duffner,P.K.,et al, 1998
A Reversible Posterior Leukoencephalopathy Syndrome
NEJM 334:494-500, Hinchey,J.,et al, 1996
Assoc of Myasthenia Gravis with Extrathymic Hodgkin's Lymphoma:Resol of Myasth Sympt Following Antineopl Therapy
Neurol 45:1019, Abrey,L.E.&Askanas,V., 1995